Indapta Therapeutics is a privately held biotechnology company.
Indapta Therapeutics has raised $50.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2025.
Indapta Therapeutics's investors include RA Capital Management, Vertex Ventures, Lonza, Cancer Prevention and Research Institute of Texas, Pontifax.
Indapta Therapeutics is headquartered in San Francisco, United States.
Indapta Therapeutics is a privately held biotechnology company.
Indapta Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Indapta Therapeutics — Funding & Investors." VCBacked, October 10, 2025, https://www.vcbacked.co/company/indapta-therapeutics. Accessed July 19, 2026.
VCBacked. (2025). Indapta Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/indapta-therapeutics
{{cite web |title=Indapta Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/indapta-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated